Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 60 of 60 entries
Sorted by: Best Match Show Resources per page
Use of mobile phone applications (apps) in preventing drug-drug interactions: A cross-sectional evaluation in a clinical setting in South India.

International journal of clinical pharmacology and therapeutics

Pavithra B, Shehnaz SI.
PMID: 34190684
Int J Clin Pharmacol Ther. 2021 Aug;59(8):549-556. doi: 10.5414/CP203949.

OBJECTIVES: With the advancement in technology, many mobile phone applications (apps) are available for preventing drug-drug interactions (DDIs). As no information is available about usage of these apps, we aimed to investigate the awareness of clinicians of Saveetha Medical...

Cite
Pavithra B, Shehnaz SI. Use of mobile phone applications (apps) in preventing drug-drug interactions: A cross-sectional evaluation in a clinical setting in South India. Int J Clin Pharmacol Ther. 2021;59(8):549-556doi: 10.5414/CP203949.
Pavithra, B., & Shehnaz, S. I. (2021). Use of mobile phone applications (apps) in preventing drug-drug interactions: A cross-sectional evaluation in a clinical setting in South India. International journal of clinical pharmacology and therapeutics, 59(8), 549-556. https://doi.org/10.5414/CP203949
Pavithra, Balaji, and Shehnaz, Syed Ilyas. "Use of mobile phone applications (apps) in preventing drug-drug interactions: A cross-sectional evaluation in a clinical setting in South India." International journal of clinical pharmacology and therapeutics vol. 59,8 (2021): 549-556. doi: https://doi.org/10.5414/CP203949
Pavithra B, Shehnaz SI. Use of mobile phone applications (apps) in preventing drug-drug interactions: A cross-sectional evaluation in a clinical setting in South India. Int J Clin Pharmacol Ther. 2021 Aug;59(8):549-556. doi: 10.5414/CP203949. PMID: 34190684.
Copy Download .nbib Format: NLM
Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: Effects of weight and total cholesterol.

International journal of clinical pharmacology and therapeutics

Zhao Y, He H, Zang Y, Zhao L, Wang X.
PMID: 34753558
Int J Clin Pharmacol Ther. 2021 Nov 10; doi: 10.5414/CP203921. Epub 2021 Nov 10.

OBJECTIVE: The existing cyclosporine (CsA) population pharmacokinetic (PPK) model does not apply well to children. The aim of the study was to establish a CsA PPK model for Chinese children with nephrotic syndrome (NS) and conduct a dosage simulation...

Cite
Zhao Y, He H, Zang Y, et al. Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: Effects of weight and total cholesterol. Int J Clin Pharmacol Ther. 2021;doi: 10.5414/CP203921.
Zhao, Y., He, H., Zang, Y., Zhao, L., & Wang, X. (2021). Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: Effects of weight and total cholesterol. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP203921
Zhao, Yiming, et al. "Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: Effects of weight and total cholesterol." International journal of clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.5414/CP203921
Zhao Y, He H, Zang Y, Zhao L, Wang X. Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: Effects of weight and total cholesterol. Int J Clin Pharmacol Ther. 2021 Nov 10; doi: 10.5414/CP203921. Epub 2021 Nov 10. PMID: 34753558.
Copy Download .nbib Format: NLM
Dose-dependent atorvastatin associated with angioedema.

International journal of clinical pharmacology and therapeutics

Al-Qaaneh AM, Obaid WT, Al-Mohammadi OS, Al-Qaaneh AM, Rabaan AA, Mustafa SM.
PMID: 34779391
Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204025. Epub 2021 Nov 15.

PURPOSE: To describe a case of angioedema associated with increasing the dose of HMG-CoA reductase inhibitor (atorvastatin) from 20 to 40 mg daily in a patient previously stable on angiotensin II receptor blocker (losartan) and calcium channel blocker (amlodipine)...

Cite
Al-Qaaneh AM, Obaid WT, Al-Mohammadi OS, et al. Dose-dependent atorvastatin associated with angioedema. Int J Clin Pharmacol Ther. 2021;doi: 10.5414/CP204025.
Al-Qaaneh, A. M., Obaid, W. T., Al-Mohammadi, O. S., Al-Qaaneh, A. M., Rabaan, A. A., & Mustafa, S. M. (2021). Dose-dependent atorvastatin associated with angioedema. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP204025
Al-Qaaneh, Ayman M, et al. "Dose-dependent atorvastatin associated with angioedema." International journal of clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.5414/CP204025
Al-Qaaneh AM, Obaid WT, Al-Mohammadi OS, Al-Qaaneh AM, Rabaan AA, Mustafa SM. Dose-dependent atorvastatin associated with angioedema. Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204025. Epub 2021 Nov 15. PMID: 34779391.
Copy Download .nbib Format: NLM
Individual drug information, analysis of prescribing in general practices. An attempt to evaluate the so-called Frankfurter Modell by computer-aided evaluation software (Hanauer Modell).

International journal of clinical pharmacology, therapy, and toxicology

Fritz A.
PMID: 1490785
Int J Clin Pharmacol Ther Toxicol. 1992 Nov;30(11):471-2.

No abstract available.

Cite
Fritz A. Individual drug information, analysis of prescribing in general practices. An attempt to evaluate the so-called Frankfurter Modell by computer-aided evaluation software (Hanauer Modell). Int J Clin Pharmacol Ther Toxicol. 1992;30(11):471-2
Fritz, A. (1992). Individual drug information, analysis of prescribing in general practices. An attempt to evaluate the so-called Frankfurter Modell by computer-aided evaluation software (Hanauer Modell). International journal of clinical pharmacology, therapy, and toxicology, 30(11), 471-2.
Fritz, A. "Individual drug information, analysis of prescribing in general practices. An attempt to evaluate the so-called Frankfurter Modell by computer-aided evaluation software (Hanauer Modell)." International journal of clinical pharmacology, therapy, and toxicology vol. 30,11 (1992): 471-2.
Fritz A. Individual drug information, analysis of prescribing in general practices. An attempt to evaluate the so-called Frankfurter Modell by computer-aided evaluation software (Hanauer Modell). Int J Clin Pharmacol Ther Toxicol. 1992 Nov;30(11):471-2. PMID: 1490785.
Copy Download .nbib Format: NLM
Ethnicity and publication policy.

International journal of clinical pharmacology and therapeutics

Woodcock BG.
PMID: 32067634
Int J Clin Pharmacol Ther. 2020 Mar;58(3):129-130. doi: 10.5414/CP203728.

No abstract available.

Cite
Woodcock BG. Ethnicity and publication policy. Int J Clin Pharmacol Ther. 2020;58(3):129-130doi: 10.5414/CP203728.
Woodcock, B. G. (2020). Ethnicity and publication policy. International journal of clinical pharmacology and therapeutics, 58(3), 129-130. https://doi.org/10.5414/CP203728
Woodcock, Barry G. "Ethnicity and publication policy." International journal of clinical pharmacology and therapeutics vol. 58,3 (2020): 129-130. doi: https://doi.org/10.5414/CP203728
Woodcock BG. Ethnicity and publication policy. Int J Clin Pharmacol Ther. 2020 Mar;58(3):129-130. doi: 10.5414/CP203728. PMID: 32067634.
Copy Download .nbib Format: NLM
A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers.

International journal of clinical pharmacology and therapeutics

Cassella JV, Spyker DA, Yeung PP.
PMID: 26445139
Int J Clin Pharmacol Ther. 2015 Oct 07; doi: 10.5414/CP202457. Epub 2015 Oct 07.

OBJECTIVE: This randomized, double-blind, active- and placebo-controlled, crossover, thorough QT study assessed the effect of two inhaled loxapine doses on cardiac repolarization as measured by corrected QT (QTc) interval in healthy subjects (ClinicalTrials.gov NCT01854710).METHODS: Subjects received two doses of...

Cite
Cassella JV, Spyker DA, Yeung PP. A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers. Int J Clin Pharmacol Ther. 2015;doi: 10.5414/CP202457.
Cassella, J. V., Spyker, D. A., & Yeung, P. P. (2015). A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP202457
Cassella, James V, et al. "A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers." International journal of clinical pharmacology and therapeutics vol. (2015). doi: https://doi.org/10.5414/CP202457
Cassella JV, Spyker DA, Yeung PP. A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers. Int J Clin Pharmacol Ther. 2015 Oct 07; doi: 10.5414/CP202457. Epub 2015 Oct 07. PMID: 26445139.
Copy Download .nbib Format: NLM
Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials.

International journal of clinical pharmacology and therapeutics

Sung YK, Lee YH.
PMID: 34622767
Int J Clin Pharmacol Ther. 2021 Oct 08; doi: 10.5414/CP204036. Epub 2021 Oct 08.

OBJECTIVES: This study aimed to evaluate the relative efficacy and safety of biologic agents in patients with rheumatoid arthritis (RA) who show inadequate response to tumor necrosis factor (TNF) inhibitors.MATERIALS AND METHODS: A meta-analysis with the Bayesian network, combining...

Cite
Sung YK, Lee YH. Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials. Int J Clin Pharmacol Ther. 2021;doi: 10.5414/CP204036.
Sung, Y. K., & Lee, Y. H. (2021). Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP204036
Sung, Yoon-Kyoung, and Lee, Young Ho. "Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials." International journal of clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.5414/CP204036
Sung YK, Lee YH. Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials. Int J Clin Pharmacol Ther. 2021 Oct 08; doi: 10.5414/CP204036. Epub 2021 Oct 08. PMID: 34622767.
Copy Download .nbib Format: NLM
Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials.

International journal of clinical pharmacology and therapeutics

Lee YH, Song GG.
PMID: 34779393
Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204097. Epub 2021 Nov 15.

OBJECTIVE: We aimed to assess the relative efficacy and safety of dotinurad (2 mg), benzbromarone (50 mg), and febuxostat (40 mg) in hyperuricemic patients with or without gout.MATERIALS AND METHODS: A Bayesian network meta-analysis was performed to combine direct...

Cite
Lee YH, Song GG. Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials. Int J Clin Pharmacol Ther. 2021;doi: 10.5414/CP204097.
Lee, Y. H., & Song, G. G. (2021). Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP204097
Lee, Young Ho, and Song, Gwan Gyu. "Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials." International journal of clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.5414/CP204097
Lee YH, Song GG. Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials. Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204097. Epub 2021 Nov 15. PMID: 34779393.
Copy Download .nbib Format: NLM
Is increased rho kinase activity/oxidative stress relationship the missing link for linezolid-induced thrombocytopenia in dialysis patients?.

International journal of clinical pharmacology and therapeutics

Sgarabotto L, Gobbi L, Calò LA.
PMID: 34779395
Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204134. Epub 2021 Nov 15.

No abstract available.

Cite
Sgarabotto L, Gobbi L, Calò LA. Is increased rho kinase activity/oxidative stress relationship the missing link for linezolid-induced thrombocytopenia in dialysis patients?. Int J Clin Pharmacol Ther. 2021;doi: 10.5414/CP204134.
Sgarabotto, L., Gobbi, L., & Calò, L. A. (2021). Is increased rho kinase activity/oxidative stress relationship the missing link for linezolid-induced thrombocytopenia in dialysis patients?. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP204134
Sgarabotto, Luca, et al. "Is increased rho kinase activity/oxidative stress relationship the missing link for linezolid-induced thrombocytopenia in dialysis patients?." International journal of clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.5414/CP204134
Sgarabotto L, Gobbi L, Calò LA. Is increased rho kinase activity/oxidative stress relationship the missing link for linezolid-induced thrombocytopenia in dialysis patients?. Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204134. Epub 2021 Nov 15. PMID: 34779395.
Copy Download .nbib Format: NLM
Intraoperative dexmedetomidine-related polyuria: A case report and review of the literature.

International journal of clinical pharmacology and therapeutics

Zhu J, Lu D, Liu JF.
PMID: 34889734
Int J Clin Pharmacol Ther. 2021 Dec 10; doi: 10.5414/CP204129. Epub 2021 Dec 10.

Dexmedetomidine-related polyuria has been observed in animal experimental studies, while only limited cases have been reported in humans. Thus, this rare effect is not well recognized. Herein, we report the case of a 26-year-old man who underwent total thyroidectomy...

Cite
Zhu J, Lu D, Liu JF. Intraoperative dexmedetomidine-related polyuria: A case report and review of the literature. Int J Clin Pharmacol Ther. 2021;doi: 10.5414/CP204129.
Zhu, J., Lu, D., & Liu, J. F. (2021). Intraoperative dexmedetomidine-related polyuria: A case report and review of the literature. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP204129
Zhu, Jiao, et al. "Intraoperative dexmedetomidine-related polyuria: A case report and review of the literature." International journal of clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.5414/CP204129
Zhu J, Lu D, Liu JF. Intraoperative dexmedetomidine-related polyuria: A case report and review of the literature. Int J Clin Pharmacol Ther. 2021 Dec 10; doi: 10.5414/CP204129. Epub 2021 Dec 10. PMID: 34889734.
Copy Download .nbib Format: NLM
Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life.

International journal of clinical pharmacology and therapeutics

Sanga M, Vaughan S, Nangosyah J, Scholz V, Fonseca S.
PMID: 34779392
Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204034. Epub 2021 Nov 15.

OBJECTIVE: Evaluate bioequivalence, based on norelgestromin (NGMN) and ethinyl estradiol (EE) plasma concentrations, and adhesion of a transdermal contraceptive patch containing a newly sourced adhesive component (test) at end of shelf life (EOSL) vs. the marketed EVRA patch (reference)...

Cite
Sanga M, Vaughan S, Nangosyah J, et al. Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life. Int J Clin Pharmacol Ther. 2021;doi: 10.5414/CP204034.
Sanga, M., Vaughan, S., Nangosyah, J., Scholz, V., & Fonseca, S. (2021). Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP204034
Sanga, Madhu, et al. "Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life." International journal of clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.5414/CP204034
Sanga M, Vaughan S, Nangosyah J, Scholz V, Fonseca S. Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life. Int J Clin Pharmacol Ther. 2021 Nov 15; doi: 10.5414/CP204034. Epub 2021 Nov 15. PMID: 34779392; PMCID: PMC8670371.
Copy Download .nbib Format: NLM
Demographic and clinical characteristics of primary care patients vaccinated against COVID-19 in spring 2021.

International journal of clinical pharmacology and therapeutics

Kostev K, Beinker P, Weber K, Bohlken J, Tanislav C.
PMID: 35006074
Int J Clin Pharmacol Ther. 2022 Jan 10; doi: 10.5414/CP204178. Epub 2022 Jan 10.

AIM: The aim of this study was to examine the age distribution and comorbidities of individuals vaccinated in primary care practices in April and May 2021.MATERIALS AND METHODS: The analysis was based on data from the IQVIA Disease Analyzer...

Cite
Kostev K, Beinker P, Weber K, et al. Demographic and clinical characteristics of primary care patients vaccinated against COVID-19 in spring 2021. Int J Clin Pharmacol Ther. 2022;doi: 10.5414/CP204178.
Kostev, K., Beinker, P., Weber, K., Bohlken, J., & Tanislav, C. (2022). Demographic and clinical characteristics of primary care patients vaccinated against COVID-19 in spring 2021. International journal of clinical pharmacology and therapeutics, . https://doi.org/10.5414/CP204178
Kostev, Karel, et al. "Demographic and clinical characteristics of primary care patients vaccinated against COVID-19 in spring 2021." International journal of clinical pharmacology and therapeutics vol. (2022). doi: https://doi.org/10.5414/CP204178
Kostev K, Beinker P, Weber K, Bohlken J, Tanislav C. Demographic and clinical characteristics of primary care patients vaccinated against COVID-19 in spring 2021. Int J Clin Pharmacol Ther. 2022 Jan 10; doi: 10.5414/CP204178. Epub 2022 Jan 10. PMID: 35006074.
Copy Download .nbib Format: NLM
Showing 49 to 60 of 60 entries